Bringing and Sharing Healthcare Expertise
HomeBasketOrder StatusSitemap
smasher-protx.gif

paypal.gif.jpg

creditcards_1.gif
 
Print-friendly version

HIV-1/2 Antibody Rapid Test OraQuick ADVANCE®

HIV-1/2 Antibody Rapid Test OraQuick ADVANCE®
Price: £417.13 Ex VAT: £355.00
Manuf part number: MIC-1001.0079
Description
Combination Test for HIV 1/2  OraQuick Rapid HIV-1 Antibody Test, is a rapid point-of-care fingerstick and venipuncture whole blood test used to aid in the diagnosis of HIV-1 infection. It is over 99 per cent accurate and is the only test approved for oral fluid, whole blood and plasma.  Ideal for both clinical and outreach settings, this simple non-invasive test offers patients accurate preliminary HIV testing, without the need for blood or needles This CLIA waived test, which detects the presence of antibodies to HIV-1, requires only a drop of blood and can produce results in 20 minutes providing Healthcare professionals with a too that can determine preliminary results in 20 minutes and advise the patient that they may be infected with HIV. This allows time for education into risk factors and steps to avoid spreading HIV to others, 25/Box
KIT
SIMPLY SWIPE - No need for Blood
 Results in 20 minutes
   
Benefits:
  • Rapid
    Provides results in 20 minutes, enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately.
  • Flexible
    Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings.
  • Accurate
    Greater than 99% agreement with confirmatory Western blot.1
  • Simple
    CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics.
  • Patient-Preferred2
    Offers patients accurate HIV testing without the need for blood or needles. Pain-free testing with oral fluid means more people get screened, more HIV positive patients are connected to care and fewer people are exposed

 
cemark_1.gif
MARKED PRODUCTS

investorsinp..gif
iso9001.gif